Odyssey Corporation Intrinsic Value
Odyssey Corporation (ODYCORP) median intrinsic value is ₹10.53 from 7 valuation models (range ₹4–₹21), vs current price ₹7.15 — +47.3% upside (Trading Below Calculated Value), margin of safety 32.1%. Browse ODYCORP financial statements for revenue, profit, balance sheet and cash flow data.
ODYCORP Valuation Methods Summary — DCF, Graham Number & P/E
Odyssey Corporation intrinsic value across 7 models vs current price ₹7.15 — upside/downside and value range per method. Also explore ODYCORP stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹7.20 | ₹5.76 - ₹8.64 | +0.7% | EPS: ₹0.60, Sector P/E: 12x |
| Book Value Method | asset | ₹17.88 | ₹16.09 - ₹19.67 | +150.1% | Book Value/Share: ₹44.47, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹14.30 | ₹12.87 - ₹15.73 | +100.0% | Revenue/Share: ₹14.74, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹10.53 | ₹9.48 - ₹11.58 | +47.3% | EBITDA: ₹8.00Cr, EV/EBITDA: 5x |
| PEG Ratio Method | growth | ₹3.84 | ₹3.46 - ₹4.22 | -46.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹4.94 | ₹4.45 - ₹5.43 | -30.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹21.45 | ₹19.30 - ₹23.60 | +200.0% | EPS: ₹0.60, BVPS: ₹44.47 |
ODYCORP Intrinsic Value vs Market Price — All Valuation Models
Odyssey Corporation fair value range ₹4–₹21 vs current market price ₹7.15 across 7 valuation models. For current market price and key ratios, visit ODYCORP screener.
ODYCORP Intrinsic Value Analysis — Undervalued or Overvalued?
Odyssey Corporation median intrinsic value ₹10.53, current price ₹7.15 — Trading Below Calculated Value by 47.3%, margin of safety 32.1%.
What is the intrinsic value of ODYCORP?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Odyssey Corporation (ODYCORP) is ₹10.53 (median value). With the current market price of ₹7.15, this represents a +47.3% variance from our estimated fair value.
The valuation range spans from ₹3.84 to ₹21.45, indicating ₹3.84 - ₹21.45.
Is ODYCORP undervalued or overvalued?
Based on our multi-method analysis, Odyssey Corporation (ODYCORP) appears to be trading below calculated value by approximately 47.3%.
ODYCORP Financial Health — Key Ratios vs Industry Benchmarks
Odyssey Corporation financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.36 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 2.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.30x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ODYCORP Cash Flow Quality — Operating & Free Cash Flow
Odyssey Corporation operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-31 Cr | ₹-41 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |